Haripriya Andanamala to Adult
This is a "connection" page, showing publications Haripriya Andanamala has written about Adult.
Connection Strength
0.026
-
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study. Lancet Digit Health. 2026 Feb; 8(2):100952.
Score: 0.026